This edition of Business of Cannabis: New York Summit has already taken place.
Search future editions →Events › Consumer Goods
Consumer Goods
300
Attendees
An elite networking summit bringing together cannabis business founders, institutional investors, state regulators, and brand developers to accelerate growth and shape policy within the New York marketplace.
Exhibitor mix: Themed around commercial pillars, showcasing brands grouped into strategic tiers such as Headline, Gold, Silver, and Bronze event sponsors.
Filter this event to your ICP.
11 exhibitors here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
⚠️ The exhibitor list for this event isn't publicly accessible yet. We'll work on it once you submit a request.
Organizer
Prohibition Partners
Private · London, United Kingdom · Founded 2017
A provider of market data, industry intelligence, consultancy, and business events for the international legal cannabis market.
Exhibitor list
11 companies are exhibiting at Business of Cannabis: New York Summit. The full list is shown below.
Why people attend
To forge strategic partnerships, secure capital investment, source retail-ready brands, and navigate the complex, evolving legal landscape of New York's commercial adult-use market.
Who attends
Exhibitor categories
Speakers
79 speakers at Business of Cannabis: New York Summit
CEO · Panaxia Israel
General Manager · Neuraxpharm France
Journalist · Business of Cannabis
Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on 'Medical Cannabis Explained'.
Also speaking at Manufacturing & Automation eXchange
Editor · Business of Cannabis
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Doctor
Dr Nicolas Authier was a key part of the pilot programme. He told Libération: 'What surprises us as doctors is the brutality of the decision.'
CEO and co-founder · Augur Associates
Benjamin-Alexandre Jeanroy is CEO and co-founder of Augur Associates, a Paris-based cannabis consultancy. He told Business of Cannabis about the pilot scheme's structure.
CEO · Curaleaf Laboratories
Chair · Medical Cannabis Clinicians Society (MCCS)
Democrat Rep.
Sessions Cannabis
"How to launch a cannabis retail brand with Sessions Cannabis"
Steven Fry of Sessions Cannabis described how he turned an Ontario retail lottery win into a cannabis retail brand. Specifically, Fry described how his approach to retail cannabis partners helps Sessions Cannabis owners set up for success.
Greek Minister for Health · Greek Ministry of Health
"Greek Health Minister to Speak in London About Greece’s Groundbreaking Medical Cannabis Programme"
As the Greek Health Minister, Adonis Georgiadis has been instrumental in spearheading the latest cannabis regulatory initiatives in Greece; where 60 year old Anna Paga recently became one of the first ever medical cannabis patients to receive a prescription in the country.
Executive Chairman · Curaleaf
Boris Jordan, the visionary behind Curaleaf, one of the largest and most successful cannabis companies globally, brings unparalleled expertise to Cannabis Europa 2024 as a preeminent leader in the sector. With a proven track record of driving innovation and growth in the industry, Jordan’s insights will be invaluable for those seeking to understand the future trajectory of medical cannabis and its impact on global markets.
Former Wimbledon Champion
Beyond the realm of sports, Pat Cash has become a vocal advocate for the medicinal applications of cannabis. Cash’s presence underscores the growing acceptance of cannabis as a legitimate medical treatment and promises to spark engaging discussions on its potential benefits, especially in the realm of sports recovery.
Co-Founder & CEO · Cansativa
CEO · High Tide Inc.
Chairman · Union of Coffeeshop Retailers (Netherlands)
+ 63 more speakers at this event.
More Consumer Goods events
Frequently asked questions